Risk Model-Based Lung Cancer Screening More Cost-Effective Than USPSTF Recs
(MedPage Today) -- Risk model-based screening for lung cancer accounting for personal risk may be more cost-effective than age- and smoking history-based screening recommended by the U.S. Preventive Services Task Force (USPSTF), according to a... (Source: MedPage Today Radiology)
Source: MedPage Today Radiology - February 7, 2023 Category: Radiology Source Type: news

Lung Cancer Screening Based on Personal Risk Is Cost-Effective
TUESDAY, Feb. 7, 2023 -- Lung cancer screening strategies based on personal risk are more cost effective than the 2021 U.S. Preventive Services Task Force (USPSTF) recommendations, according to a study published online Feb. 7 in the Annals of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 7, 2023 Category: Pharmaceuticals Source Type: news

Targeted Drug Tagrisso Could Be Advance Against Lung Cancer
MONDAY, Feb. 6, 2023 -- The best treatment for a genetically driven form of lung cancer continues to show lasting benefits, a new clinical trial update shows. Tagrisso (osimertinib) nearly doubles disease-free survival in earlier-stage patients... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 6, 2023 Category: General Medicine Source Type: news

COVID-19-dampened lung cancer screening rates have recovered, sort of
Rates of low-dose CT (LDCT) screening for lung cancer dropped significantl...Read more on AuntMinnie.comRelated Reading: Community health advisors improve LDCT lung cancer screening rates Don't go too low on radiation dose for CT lung cancer screening 20-year study results confirm lung cancer screening's effectiveness ALA: Only 5.8% of eligible Americans undergo lung cancer screening Radiologists detect more lung nodules on CT with help from AI (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 6, 2023 Category: Radiology Source Type: news

Breast and lung cancer screening down by up to 25% two years into pandemic, study warns
Researchers at the University of Texas found that cancer screenings decreased when Covid infection rates were higher, but rose when they started to fall. (Source: the Mail online | Health)
Source: the Mail online | Health - February 3, 2023 Category: Consumer Health News Source Type: news

NSCLC Survival Improved With FDG PET/CT Imaging Before Radiation Therapy
FRIDAY, Feb. 3, 2023 -- Almost half of patients with non-small cell lung cancer (NSCLC) are not being imaged in accordance with national guidelines prior to subsequent radiation therapy, according to a study recently published in the Journal of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 3, 2023 Category: Pharmaceuticals Source Type: news

Shedding light on the genetic causes of lung cancer
<img width="100" src="https://factor.niehs.nih.gov/sites/niehs-factor/files/styles/large/public/2019/6/papers/lung-cancer/thumb870603.jpg?itok=qfqhutj5" /><br /><p>When an NIEHS-led team disrupted a stress response pathway in mice, lung squamous cell carcinoma developed, suggesting a treatment target.</p> (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - February 3, 2023 Category: Environmental Health Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results for 2022 despite decline in demand for COVID-19 products
Basel, 2 February 2023Group sales grow by 2%1 at constant exchange rates (CER) and 1% in Swiss francs, despite lower COVID-19-related sales in both divisionsPharmaceuticals Division salesincrease by 2%; continued strong growth of newer medicines more than compensating for the impact of biosimilars and lower sales of Actemra/RoActemra (severe COVID-19)Diagnostics Division salesgrow by 3%; ongoing strong momentum in base business (+7%) more than compensating for the continuing decline in the demand for COVID-19 tests in the second half of the yearHighlightsin the fourth quarter of 2022 (incl. January 2023):US approvals ofLun...
Source: Roche Media News - February 2, 2023 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results for 2022 despite decline in demand for COVID-19 products
Group sales grow by 2%1 at constant exchange rates (CER) and 1% in Swiss francs, despite lower COVID-19-related sales in both divisionsPharmaceuticals Division salesincrease by 2%; continued strong growth of newer medicines more than compensating for the impact of biosimilars and lower sales of Actemra/RoActemra (severe COVID-19)Diagnostics Division salesgrow by 3%; ongoing strong momentum in base business (+7%) more than compensating for the continuing decline in the demand for COVID-19 tests in the second half of the yearHighlightsin the fourth quarter of 2022 (incl. January 2023):US approvals ofLunsumio (follicular lymp...
Source: Roche Investor Update - February 2, 2023 Category: Pharmaceuticals Source Type: news

Bispecific Antibody Active in Relapsed/Refractory Small Cell Lung Cancer
(MedPage Today) -- A first-in-class bispecific antibody achieved durable responses in a fourth of patients with advanced small cell lung cancer (SCLC) and disease control in more than half, a preliminary clinical trial showed. Tarlatamab, targeting... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 2, 2023 Category: Hematology Source Type: news

Women who have never smoked are being diagnosed with lung cancer and it's confounding both doctors and patients
When many people think of an average lung cancer patient, they often imagine an older man smoking. But the face of lung cancer has changed. Over the past 15 years, more women, never smokers and younger people are being diagnosed with lung cancer. In fact, lung cancer is the leading cause of cancer…#ovarian #radon #brca2 #estelamarirodriguez #universityofmiami (Source: Reuters: Health)
Source: Reuters: Health - February 1, 2023 Category: Consumer Health News Source Type: news

This software tries to spot lung cancer years earlier. Can it?
Lung cancer is the deadliest kind of cancer, so catching it early is one of the best ways for patients to survive. Now researchers have created an artificial intelligence tool that could predict whether a person will get lung cancer up to six years in advance, paving the way for doctors to spot…#harvards #sybil #greek #taiwan #cancer #mit #harvard #netherlands (Source: Reuters: Health)
Source: Reuters: Health - February 1, 2023 Category: Consumer Health News Source Type: news

Shifting the Perspective of Therapy Options in Early-Stage NSCLC Shifting the Perspective of Therapy Options in Early-Stage NSCLC
Liza Villaruz, MD, considers how her perspective on early-stage non –small cell lung cancer has changed over time.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 30, 2023 Category: Consumer Health News Tags: None MDAngle Source Type: news

Early-Stage Non-Small Cell Lung Cancer: Mitigating the Rigors of Therapy Early-Stage Non-Small Cell Lung Cancer: Mitigating the Rigors of Therapy
Mark Socinski, MD, considers the potential means to identify patients with lung cancer who may not need adjuvant therapy.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 30, 2023 Category: Consumer Health News Tags: Hematology-Oncology MDAngle Source Type: news

A Look Back at the Rapidly Evolving Treatment Landscape for Early-Stage NSCLC A Look Back at the Rapidly Evolving Treatment Landscape for Early-Stage NSCLC
Mark Socinski, MD, recalls the limited scope of lung cancer staging that he witnessed early in his career.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 30, 2023 Category: Consumer Health News Tags: Hematology-Oncology MDAngle Source Type: news